Faculty profile

Hermann Nabi

ResearcherUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Hermann Nabi

Researcher

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
33 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.
Supervised 1 trainee who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cancer

Latest papers

A complex intervention to improve life experience during and after acute treatment for breast cancer: Preliminary results from intervention development for the Continuum PAROLE-Onco 360 program.
Canadian journal of public health = Revue canadienne de sante publique · 2026
Corrigendum to "First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?" [Cancer Treat. Rev. 135 (2025) 102909].
Cancer treatment reviews · 2026 · senior author
Genetic counseling services for hereditary breast and ovarian cancer: patients' experience and satisfaction with different service models.
European journal of human genetics : EJHG · 2026 · senior author

All 51 publications

Latest funding

Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies
CIHR · 2025 · Co-investigator
Development of statistical methods for estimating optimal adaptive treatment strategies with survival outcomes
CIHR · 2024 · Co-investigator
$271,576
What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer
CIHR · 2021 · Nominated PI
$37,343

All 6 grants and awards

51 publications.

A complex intervention to improve life experience during and after acute treatment for breast cancer: Preliminary results from intervention development for the Continuum PAROLE-Onco 360 program.

Pomey MP, Nabi H, Coté MA, Iliescu Nelea M, Boubaker A, Vialaron C, Normandin L, Lesperance-Huot C

Canadian journal of public health = Revue canadienne de sante publique2026

DOI: 10.17269/s41997-025-01095-5 PMID: 41530501

Corrigendum to "First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?" [Cancer Treat. Rev. 135 (2025) 102909].

Nguyen Van Long F, Poirier B, Desbiens C, Perron M, Paquet C, Ouellet C, Diorio C, Lemieux J, Nabi H

Cancer treatment reviews2026Senior author

DOI: 10.1016/j.ctrv.2026.103088 PMID: 41605776

Genetic counseling services for hereditary breast and ovarian cancer: patients' experience and satisfaction with different service models.

Haroun O, Lapointe J, Guérard R, Bergeron AS, Raîche C, Chiquette J, Bouchard K, Pomey MP, Hébert J, Olivier Chevrier G, Lachapelle P, Omeranovic A, Côté M, Boily L, Brisson C, Gekas J, Cruz-Marino T, Touhami O, Blanchet Saint-Pierre A, Gagnon S, Boisvert K, Brousseau C, Castonguay L, Gosselin I, Renaud MC, Ruiz Mangas MG, Paquet-Beaupré A, Bélanger ME, Racine MM, Roy MC, Blanchette S, Faucher V, Leblanc J, Dubeau ME, Cavaillé M, Plante M, Desbiens C, Beaumont M, Simard J, Dorval M, Nabi H

European journal of human genetics : EJHG2026Senior author

DOI: 10.1038/s41431-026-02031-y PMID: 41699267

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.

Lemieux J, Côté I, Lemay M, Lauzier S, Després P, Desbiens C, Doyle C, Poirier B, Baghdadli A, Di Schiavi Trotta L, Nabi H

Current oncology (Toronto, Ont.)2026Senior author

DOI: 10.3390/curroncol33050272 PMID: 42187589

Canadian Women’s Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project

Brooks JD, Blackmore KM, Ngo NNM, Walker MJ, Chang A, Lambert-Côté L, Turgeon A, Lofters AK, Nabi H, Antoniou AC

Clinical Breast Cancer20262 citations

DOI: 10.1016/j.clbc.2025.12.009

Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada

Safieh-Garabedian N, Antoniou AC, Brooks J, Carroll J, Cavaillé M, Chiquette J, DeCoteau M, Doyle G, Eisen A, Eloy L

Communications Medicine2026

DOI: 10.1038/s43856-026-01582-x

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project

Yang X, Usher-Smith JA, Blackmore KM, Brooks JD, Bell KA, Carver T, Chang A, Chiquette J, Easton DF, Eisen A

Cancers2026

DOI: 10.3390/cancers18091482

Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional study.

Omeranovic A, Lapointe J, Fortier P, Bergeron AS, Dorval M, Chiquette J, Boubaker A, Eloy L, Turgeon A, Lambert-Côté L, Joly Y, Brooks JD, Walker MJ, Stockley T, Pashayan N, Antoniou A, Easton D, Chiarelli AM, Knoppers B, Simard J, Nabi H

BMJ open2025Senior author

DOI: 10.1136/bmjopen-2024-093936 PMID: 40316347

Using Machine Learning to Improve Control for Confounding in the Dynamic Weighted Ordinary Least Squares Estimator of Optimal Adaptive Treatment Strategies.

Trenou KC, Mésidor M, Eslami A, Nabi H, Diorio C, Talbot D

Biometrical journal. Biometrische Zeitschrift2025

DOI: 10.1002/bimj.70068 PMID: 40726439

Structural equation modeling of factors influencing women's attitudes, comfort and willingness toward risk-stratified breast cancer screening.

Mbuya-Bienge C, Pashayan N, Simard J, Nabi H

Scientific reports2025Senior author

DOI: 10.1038/s41598-025-13641-9 PMID: 40738960

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Cancer Dear Professor Nabi, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "A complex intervention to improve life experience during and after acute treatment for breast cancer: Preliminary results from intervention development for the Continuum PAROLE-Onco 360 program." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Hermann Nabi

Research

Latest papers

Latest funding

A complex intervention to improve life experience during and after acute treatment for breast cancer: Preliminary results from intervention development for the Continuum PAROLE-Onco 360 program.

Corrigendum to "First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?" [Cancer Treat. Rev. 135 (2025) 102909].

Genetic counseling services for hereditary breast and ovarian cancer: patients' experience and satisfaction with different service models.

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.

Canadian Women’s Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project

Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project

Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional study.

Using Machine Learning to Improve Control for Confounding in the Dynamic Weighted Ordinary Least Squares Estimator of Optimal Adaptive Treatment Strategies.

Structural equation modeling of factors influencing women's attitudes, comfort and willingness toward risk-stratified breast cancer screening.

Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies

Development of statistical methods for estimating optimal adaptive treatment strategies with survival outcomes

What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer

Développement d'un cadre d'évaluation optimisé pour une introduction responsable des tests de signatures génomiques dans le système de santé

Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors

Inégalités sociales dans les trajectoires d'usage des traitements oraux pour le cancer du sein : Une comparaison France - Québec

Frequent collaborators

Jacques Simard

Yann Joly

Andrea Eisen

Caroline Diorio

Andrea Eisen

Sophie Lauzier

Michael Wolfson

Maude Laberge

Bruno Gagnon

Jennifer Brooks

Marie-Pascale Pomey

Marie-Pascale Pomey

Vincent Fradet

Denis Talbot

Laurence Guillaumie

June Carroll

Tracy Stockley

Meghan Walker

Jean-Sébastien Paquette

Bartha Knoppers

Steve Bilodeau

Aisha Lofters

Aisha Lofters